Annis Gardner Whiting Capital Advisors’s Humana HUM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-6
Closed -$1.05K – 749
2026
Q1
$1.05K Sell
6
-24
-80% -$4.92K ﹤0.01% 1141
2025
Q4
$7.71K Buy
30
+1
+3% +$262 ﹤0.01% 812
2025
Q3
$7.57K Buy
29
+3
+12% +$789 ﹤0.01% 739
2025
Q2
$6.38K Sell
26
-17
-40% -$4.24K ﹤0.01% 810
2025
Q1
$11.4K Sell
43
-5
-10% -$1.35K ﹤0.01% 530
2024
Q4
$12.2K Sell
48
-113
-70% -$30.3K ﹤0.01% 507
2024
Q3
$51.1K Sell
161
-13
-7% -$4.63K 0.01% 365
2024
Q2
$65.2K Hold
174
– – 0.02% 371
2024
Q1
$60.5K Sell
174
-24
-12% -$9.1K 0.02% 360
2023
Q4
$90.8K Hold
198
– – 0.04% 232
2023
Q3
$96.5K Buy
+198
New +$93K 0.05% 214

Other funds holding HUM

Annis Gardner Whiting Capital Advisors's HUM Position: Q2 2026 in Review

Annis Gardner Whiting Capital Advisors sold out of Humana (HUM) in Q2 2026, closing a stake of 6 shares — an estimated $1.05K sold.

Annis Gardner Whiting Capital Advisors first reported a position in HUM in Q3 2023 and held it in 11 quarters. The position peaked at $96.5K in Q3 2023. 928 funds tracked by Wall St. Rank hold HUM as of Q2 2026.

  • Annis Gardner Whiting Capital Advisors reported no remaining Humana position as of Q2 2026 after selling out during the quarter.
  • Annis Gardner Whiting Capital Advisors sold 6 Humana shares in Q2 2026, an estimated $1.05K.
  • Annis Gardner Whiting Capital Advisors first reported a position in Humana in Q3 2023 and held it in 11 quarters.
  • Annis Gardner Whiting Capital Advisors's Humana position peaked at $96.5K in Q3 2023.
  • 928 funds tracked by Wall St. Rank held Humana as of Q2 2026.

Based on Annis Gardner Whiting Capital Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.